Zynex ROE 2010-2025 | ZYXI

Current and historical return on equity (ROE) values for Zynex (ZYXI) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Zynex ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2025-03-31 $-0.01B $0.02B -25.40%
2024-12-31 $0.00B $0.04B 5.80%
2024-09-30 $0.00B $0.04B 10.81%
2024-06-30 $0.01B $0.03B 14.04%
2024-03-31 $0.01B $0.03B 16.00%
2023-12-31 $0.01B $0.05B 17.32%
2023-09-30 $0.02B $0.06B 25.50%
2023-06-30 $0.02B $0.06B 26.46%
2023-03-31 $0.02B $0.06B 25.76%
2022-12-31 $0.02B $0.07B 23.19%
2022-09-30 $0.02B $0.07B 25.35%
2022-06-30 $0.02B $0.07B 26.95%
2022-03-31 $0.02B $0.08B 28.15%
2021-12-31 $0.02B $0.07B 27.20%
2021-09-30 $0.01B $0.06B 17.17%
2021-06-30 $0.01B $0.06B 8.93%
2021-03-31 $0.01B $0.06B 10.31%
2020-12-31 $0.01B $0.06B 22.36%
2020-09-30 $0.01B $0.05B 32.26%
2020-06-30 $0.01B $0.03B 51.16%
2020-03-31 $0.01B $0.02B 54.79%
2019-12-31 $0.01B $0.02B 58.06%
2019-09-30 $0.01B $0.02B 70.59%
2019-06-30 $0.01B $0.01B 90.91%
2019-03-31 $0.01B $0.01B 105.26%
2018-12-31 $0.01B $0.01B 129.03%
2018-09-30 $0.01B $0.01B 148.15%
2018-06-30 $0.01B $0.01B 180.00%
2018-03-31 $0.01B $0.01B 360.00%
2017-12-31 $0.01B $0.01B 1400.00%
2017-09-30 $0.00B $0.00B -228.57%
2017-06-30 $0.00B $0.00B -92.31%
2017-03-31 $0.00B $0.00B -25.00%
2016-12-31 $0.00B $0.00B -23.53%
2016-09-30 $0.00B $0.00B 0.00%
2016-06-30 $0.00B $-0.01B 25.00%
2016-03-31 $0.00B $0.00B 28.57%
2015-12-31 $0.00B $0.00B 66.67%
2015-09-30 $0.00B $0.00B 0.00%
2015-06-30 $0.00B $0.00B 0.00%
2015-03-31 $-0.01B $0.00B 342.86%
2014-12-31 $-0.01B $0.00B 1200.00%
2014-09-30 $-0.01B $0.00B -1200.00%
2014-06-30 $-0.01B $0.00B -346.67%
2014-03-31 $-0.01B $0.00B -133.33%
2013-12-31 $-0.01B $0.01B -88.89%
2013-09-30 $0.00B $0.01B -27.91%
2013-06-30 $0.00B $0.01B -17.39%
2013-03-31 $0.00B $0.01B 0.00%
2012-12-31 $0.00B $0.01B 0.00%
2012-09-30 $0.00B $0.01B 9.09%
2012-06-30 $0.00B $0.01B 19.51%
2012-03-31 $0.00B $0.01B 20.51%
2011-12-31 $0.00B $0.01B 22.22%
2011-09-30 $0.00B $0.01B 11.76%
2011-06-30 $0.00B $0.01B 0.00%
2011-03-31 $0.00B $0.01B 0.00%
2010-12-31 $0.00B $0.01B 0.00%
2010-09-30 $0.00B $0.01B 0.00%
2010-06-30 $0.00B $0.01B 0.00%
2010-03-31 $0.00B $0.01B 14.81%
2009-12-31 $0.00B $0.01B 32.00%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.073B $0.192B
Zynex, Inc. engineers, manufactures, markets, and sells medical devices for the electrotherapy, and stroke and spinal cord injury rehabilitation markets primarily in the United States. The company primarily offers electrotherapy products for pain relief and pain management; and NeuroMove for stroke and spinal cord injury rehabilitation. The company's product lines are fully developed, FDA-cleared, commercially sold, and have been developed to uphold the Company's mission of improving the quality of life for patients suffering from impaired mobility due to stroke, spinal cord injury, or debilitating and chronic pain. Zynex markets its products through commissioned and independent sales representatives, as well as directly to end users through advertisements and articles in relevant publications and on the Internet. The company is headquartered in Littleton, Colorado.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $230.372B 27.70
Boston Scientific (BSX) United States $149.971B 37.54
Stryker (SYK) United States $142.469B 29.79
EssilorLuxottica (ESLOY) France $128.310B 0.00
Medtronic (MDT) Ireland $109.952B 15.59
Lonza Group Ag (LZAGY) Switzerland $49.265B 0.00
Haleon (HLN) United Kingdom $47.015B 26.80
ResMed (RMD) United States $36.786B 27.63
GE HealthCare Technologies (GEHC) United States $32.917B 15.63
Agilent Technologies (A) United States $32.815B 21.39
Terumo (TRUMY) Japan $26.606B 34.56
Koninklijke Philips (PHG) Netherlands $21.242B 14.90
Insulet (PODD) United States $21.238B 83.37
Zimmer Biomet Holdings (ZBH) United States $17.915B 11.51
Baxter (BAX) United States $15.293B 11.42
Smith & Nephew SNATS (SNN) United Kingdom $12.517B 0.00
Demant (WILYY) Denmark $9.110B 0.00
Sunny Optical Technology (SNPTF) China $9.087B 0.00
Bio-Rad Laboratories (BIO) United States $6.313B 21.97
Lantheus Holdings (LNTH) United States $5.465B 13.78
Prestige Consumer Healthcare (PBH) United States $4.133B 18.46
Perrigo (PRGO) Ireland $3.618B 9.17
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Haemonetics (HAE) United States $3.366B 15.33
ICU Medical (ICUI) United States $3.165B 23.34
Envista Holdings (NVST) United States $3.154B 26.21
GN Store Nord (GNNDY) Denmark $2.272B 18.82
QuidelOrtho (QDEL) United States $1.916B 13.18
LeMaitre Vascular (LMAT) United States $1.846B 41.26
AtriCure (ATRC) United States $1.565B 0.00
Acuren (TIC) United States $1.335B 0.00
AdaptHealth (AHCO) United States $1.144B 11.62
Neogen (NEOG) United States $1.083B 13.86
Green Thumb Industries (GTBIF) United States $1.059B 23.81
BioLife Solutions (BLFS) United States $1.022B 0.00
Phibro Animal Health (PAHC) United States $0.971B 12.41
InMode (INMD) Israel $0.843B 8.50
Kestra Medical Technologies (KMTS) United States $0.796B 0.00
CeriBell (CBLL) United States $0.643B 0.00
Evolus (EOLS) United States $0.600B 0.00
Owens & Minor (OMI) United States $0.576B 4.78
Curaleaf Holdings (CURLF) Canada $0.547B 0.00
Capricor Therapeutics (CAPR) United States $0.545B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.512B 0.00
Valneva SE (VALN) France $0.487B 0.00
Surmodics (SRDX) United States $0.417B 0.00
Tilray Brands (TLRY) Canada $0.386B 0.00
SNDL (SNDL) Canada $0.334B 0.00
VAREX IMAGING (VREX) United States $0.316B 11.62
SEMPERIT AG HLD (SEIGY) Austria $0.307B 0.00
Sanuwave Health (SNWV) United States $0.282B 0.00
Aurora Cannabis (ACB) Canada $0.263B 78.00
Viemed Healthcare (VMD) United States $0.260B 21.93
Cerus (CERS) United States $0.256B 0.00
Quanterix (QTRX) United States $0.248B 0.00
Sanara MedTech (SMTI) United States $0.245B 0.00
ZimVie (ZIMV) United States $0.240B 10.90
Canopy Growth (CGC) Canada $0.237B 0.00
Cresco Labs (CRLBF) United States $0.236B 0.00
Biote (BTMD) United States $0.218B 6.14
OraSure Technologies (OSUR) United States $0.215B 0.00
Brainsway (BWAY) Israel $0.208B 55.15
TriSalus Life Sciences (TLSI) United States $0.204B 0.00
Verano Holdings (VRNOF) United States $0.192B 0.00
Omeros (OMER) United States $0.189B 0.00
High Tide (HITI) Canada $0.178B 0.00
Organigram Global (OGI) Canada $0.177B 0.00
Utah Medical Products (UTMD) United States $0.174B 14.20
Exagen (XGN) United States $0.157B 0.00
Vireo Growth (VREOF) United States $0.133B 0.00
FitLife Brands (FTLF) United States $0.128B 15.76
Jin Medical (ZJYL) China $0.110B 0.00
Veru (VERU) United States $0.089B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.088B 0.00
Fonar (FONR) United States $0.087B 11.25
MacroGenics (MGNX) United States $0.086B 0.00
Quipt Home Medical (QIPT) United States $0.078B 0.00
TerrAscend (TSNDF) Canada $0.077B 0.00
Agape ATP (ATPC) $0.076B 0.00
Cytosorbents (CTSO) United States $0.073B 0.00
InterCure (INCR) Israel $0.068B 0.00
Apyx Medical (APYX) United States $0.065B 0.00
Jushi Holdings (JUSHF) United States $0.057B 0.00
ImmuCell (ICCC) United States $0.055B 0.00
Modular Medical (MODD) United States $0.044B 0.00
Nephros (NEPH) United States $0.038B 51.14
United-Guardian (UG) United States $0.038B 12.98
Rockwell Medical (RMTI) United States $0.032B 0.00
Safety Shot (SHOT) United States $0.023B 0.00
Allurion Technologies (ALUR) United States $0.018B 0.00
Cellectar Biosciences (CLRB) United States $0.017B 0.00
Flora Growth (FLGC) United States $0.016B 0.00
INLIF (INLF) $0.013B 0.00
Meihua Medical Technologies (MHUA) China $0.013B 0.00
Trinity Biotech (TRIB) Ireland $0.010B 0.00
Senestech (SNES) United States $0.008B 0.00
Innovative Eyewear (LUCY) United States $0.007B 0.00
IM Cannabis (IMCC) Canada $0.007B 0.00
GlucoTrack (GCTK) United States $0.003B 0.00
Akanda (AKAN) Canada $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00